RX

Prometheus Biosciences IncNASDAQ RXDX Stock Report

Last reporting period 31 Mar, 2023

Updated —

Last price

Market cap $B

9.559

Middle

Exchange

XNAS - Nasdaq

View Section: Company Analysis

Prometheus Biosciences Rating

RX

RXDX stock is not rated by Eyestock analysis.

The financial statements data is not enough to calculate the rating

Discover High-rated Companies


View Section: Valuation